MC1Rgene variants and nonmelanoma skin cancer: a pooled analysis from the M-SKIP project

¹European Institute of Oncology, Milan, Italy, ²University of L'Aquila, L'Aquila, Italy, ³Erasmus MC University Medical Center, Rotterdam, the Netherlands, ⁴Brigham and Women's Hospital and Harvard Medical School, Boston, MA, U.S.A., ⁵German Cancer Research Center, Heidelberg, Germany,⁶Leiden University Medical Center, Leiden, the Netherlands, ⁷Institute of Forensic Research, Krakow, Poland, ⁸Murdoch Children's Research Institute, Royal Children's Hospital, Vic., Australia, ⁹Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tas., Australia, ¹⁰Oslo University Hospital, Oslo, Norway, ¹¹International Prevention Research Institute, Lyon, France, ¹²University of Murcia, Murcia, Spain, ¹³Moffitt Cancer Center, Tampa, FL, U.S.A., ¹⁴National Cancer Institute, NIH, Bethesda, MD, U.S.A., ¹⁵University of Ottawa, Ottawa, ON, Canada,¹⁶Institute of Cancer and Pathology, University of Leeds, Leeds, U.K. and¹⁷UCL Institute of Child Health, London, U.K.